Micro Dosing Wegovy: Understanding the Decision Before You Make It

What people actually mean when they talk about micro dosing semaglutide

The phrase "micro dosing" circulates widely on forums and social media, but it is used to describe at least three different things: staying on the 0.25 mg starting dose indefinitely; pausing a dose increase to ride out nausea; or deliberately reducing from a higher maintenance dose because of tolerability problems. These are meaningfully different situations, even though the label applied to all of them sounds the same.

The licensed semaglutide titration for weight management moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and then 2.4 mg, with roughly four weeks at each level. The NHS describes this schedule on its semaglutide medicines page, the dose steps are designed to let your body adjust gradually, reducing the nausea and gastrointestinal discomfort that many people notice early in treatment. That is not micro dosing in any clinical sense; it is simply the licensed escalation pathway doing its job.

Where the concept of micro dosing gains traction is in two narrower situations: patients who find even the 0.25 mg dose difficult to tolerate and want to stay there longer, and patients who have reached a maintenance dose and want to reduce it slightly to improve day-to-day comfort. Both scenarios deserve a proper answer, because the implications are quite different. The standard Wegovy dosing schedule covers what the licence specifies; this page is about what happens when someone considers departing from it.

Why the titration schedule matters for how well Wegovy works

Semaglutide's weight-loss results in clinical trials were measured at the 2.4 mg maintenance dose. In the STEP 1 trial, published in the New England Journal of Medicine, adults with obesity who reached and stayed on the 2.4 mg dose over 68 weeks lost around 15% of their body weight on average, alongside lifestyle changes. That figure is not replicable at 0.25 mg or 0.5 mg, the appetite-regulatory effect scales with dose, and lower doses produce a correspondingly smaller signal.

This matters because some of the appeal of staying at a very low dose is the belief that the medicine is still working meaningfully. It may be working to some degree (semaglutide acts on GLP-1 receptors involved in appetite and fullness at any dose) but the clinical evidence base for meaningful weight loss sits firmly at the maintenance level. If you are considering whether a lower dose is achieving something useful for you, that is a question a prescriber can help you answer with a view of your actual progress, not something a dosing chart resolves on its own.

There is also a practical consideration. The Wegovy dosing chart shows the scheduled escalation as a pathway, not a menu. Staying off the pathway for a sustained period means you are using the medicine outside its licensed indication, which affects how your prescriber can continue to support you.

The case for slower titration, and why it still needs clinical oversight

Here is what is true and worth saying plainly: some people do better with a slower approach. GI side effects (nausea, loose stools, indigestion, fatigue in the early weeks) are the most common reason people stop treatment before they have had a chance to see results. If a slower escalation keeps someone in treatment rather than abandoning it, there is a reasonable clinical argument for that flexibility. The question is who makes that decision and on what basis.

A prescriber reviewing your progress can assess whether a slower pace is genuinely appropriate for your situation, or whether what feels like tolerability is actually plateau, and whether a different approach to managing side effects (hydration, smaller meals, timing the injection) might let the schedule continue. Self-directed micro dosing bypasses that clinical conversation entirely, which is the problem. It is also worth knowing that the proposed benefits of micro dosing semaglutide are discussed in more depth elsewhere, including the limitations of the evidence behind them.

If you are finding the standard schedule difficult, the most useful thing you can do is tell your prescriber before adjusting your dose independently. At nume, aftercare is available seven days a week precisely for moments like this, a question about whether to delay your next step is exactly the kind of thing our team is there to field, not something to resolve through a forum thread. Timing matters practically too: if you are mid-way through a dose step over a bank holiday or are waiting for a payday delivery, flagging it early gives your prescriber time to advise before the next pen is due.

What your prescriber actually needs to know before any dose change

If you are actively considering changing your dose (in any direction) the conversation with your prescriber should cover a few specific things. First, how much weight have you lost so far, and over what period? This is the clearest signal of whether the current dose is working. Second, are your side effects constant, or do they cluster around the injection day and then improve? That pattern usually responds better to timing or dietary adjustments than to dose reduction. Third, are you asking about a temporary pause in escalation, or an indefinite stay at a lower dose? These carry different implications, and our guide to microdosing Wegovy goes into the practical detail of what each approach actually involves.

The MHRA's Drug Safety Update index documents evolving safety guidance for GLP-1 medicines; a prescriber who stays current with those communications is in a better position to advise you than any general resource. At nume, every repeat order is clinically re-reviewed before it is dispensed, which means there is a natural checkpoint built in at each stage of treatment. If your dosing pattern has drifted from the licensed schedule, that review is the right moment to discuss it openly.

Treatment that actually works at a dose you can sustain is the goal, and that goal is best reached through your prescriber rather than around them. If you would like to explore whether Wegovy is appropriate for you in the first place, the free consultation is the right starting point.